Gerresheimer Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St · 10/16 04:05

Gerresheimer (ETR:GXI) Third Quarter 2024 Results

Key Financial Results

  • Revenue: €498.5m (up 2.2% from 3Q 2023).
  • Net income: €27.2m (down 2.9% from 3Q 2023).
  • Profit margin: 5.5% (down from 5.7% in 3Q 2023). The decrease in margin was driven by higher expenses.
  • EPS: €0.79 (down from €0.81 in 3Q 2023).
earnings-and-revenue-growth
XTRA:GXI Earnings and Revenue Growth October 16th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Gerresheimer Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 14%.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Life Sciences industry in Europe.

Performance of the market in Germany.

The company's shares are up 6.7% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Gerresheimer, and understanding this should be part of your investment process.